Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 111 | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | 548.05 USD | +1.44% | +8.77% | +14.33% | +38.57% | 138.91 B USD | ||
| 197 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 834.04 USD | +0.90% | +4.03% | +25.93% | +41.11% | 85.87 B USD | ||
| 263 | ARGX argenx SE - American Depositary Shares | 1039.78 USD | +0.16% | +12.13% | +13.64% | +51.67% | 64.35 B USD | ||
| 288 | MRNA Moderna, Inc. - Common Stock | 145.13 USD | +8.86% | +125.88% | +164.64% | +435.14% | 57.94 B USD | ||
| 352 | RVMD Revolution Medicines, Inc. - Common Stock | 209.46 USD | -1.08% | +2.67% | +10.88% | +278.09% | 44.89 B USD | ||
| 445 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 236.22 USD | +3.02% | +4.63% | -13.94% | -47.90% | 31.61 B USD | ||
| 477 | BNTX BioNTech SE - American Depositary Shares | 116.57 USD | +5.12% | +25.05% | +30.27% | +5.14% | 27.97 B USD | ||
| 484 | INSM Insmed Incorporated - Common Stock | 125.77 USD | +0.55% | +0.85% | +17.51% | -22.39% | 27.47 B USD | ||
| 488 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 61.31 USD | +1.21% | +5.05% | +4.22% | +64.55% | 27.38 B USD | ||
| 505 | ROIV Roivant Sciences Ltd. - Common Shares | 36.30 USD | -1.47% | +0.22% | +3.21% | +98.25% | 26.22 B USD | ||
| 508 | INCY Incyte Corporation - Common Stock | 127.81 USD | +0.46% | +6.37% | +8.62% | +50.36% | 25.91 B USD | ||
| 575 | UTHR United Therapeutics Corporation - Common Stock | 513.12 USD | -1.51% | +2.22% | -3.13% | +65.14% | 22.01 B USD | ||
| 676 | JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 254.28 USD | +2.24% | +3.83% | -0.20% | +81.63% | 16.51 B USD | ||
| 687 | BBIO BridgeBio Pharma, Inc. - Common Stock | 81.50 USD | -1.74% | +2.97% | -3.02% | +42.98% | 15.93 B USD | ||
| 696 | ASND Ascendis Pharma A/S - American Depositary Shares | 253.29 USD | -0.60% | +2.80% | -0.89% | +23.51% | 15.70 B USD | ||
| 773 | EXEL Exelixis, Inc. - Common Stock | 54.08 USD | +0.73% | +5.52% | -3.10% | +38.52% | 13.40 B USD | ||
| 779 | CORT Corcept Therapeutics Incorporated - Common Stock | 122.25 USD | +0.99% | +6.30% | +33.46% | +66.62% | 13.22 B USD | ||
| 794 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 66.70 USD | -1.45% | -0.45% | +11.37% | +13.28% | 12.91 B USD | ||
| 818 | ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 87.11 USD | -0.41% | +0.78% | +1.30% | +122.79% | 12.30 B USD | ||
| 821 | HALO Halozyme Therapeutics, Inc. - Common Stock | 108.17 USD | +1.93% | +9.42% | +31.26% | +61.93% | 12.28 B USD |
Nachrichten Biotechnology Stocks
Deutsche Bank stuft Argenx Aktie wegen Bewertung auf ’Hold’ herab
Crinetics Pharmaceuticals Aktie erreicht Allzeithoch bei 84,8 USD
H.C. Wainwright bekräftigt "Buy"-Rating für Biomea Fusion nach Meilenstein in Diabetes-Studie
FDA verlängert Prüffrist für Capricors Deramiocel bis 22. November; HC Wainwright äußert sich
BMO bestätigt Rating für Scholar Rock Aktie nach Änderung im Zulassungsantrag
Warum die Aktie von Eli Lilly heute nachgibt
FDA verlängert Prüfungsfrist für Capricors Deramiocel auf den 22. November
Gainers Biotechnology Stocks
LIMN Liminatus Pharma, Inc. - Class A Common Stock | 5.15 | +4581.82% |
SCNI Scinai Immunotherapeutics Ltd - American Depositary Shares | 3.22 | +1010.34% |
ELAB PMGC Holdings Inc. - Common Stock | 6.66 | +991.80% |
HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.87 | +102.33% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.55 | +38.39% |
NTRBW Nutriband Inc. - Warrant | 0.5000 | +25.06% |
ARCT Arcturus Therapeutics Holdings Inc. - Common Stock | 13.45 | +22.38% |
Losers Biotechnology Stocks
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0010 | -52.38% |
OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
XCUR Exicure, Inc. - Common Stock | 1.15 | -11.54% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.39 | -11.36% |
CURX Curanex Pharmaceuticals Inc - Common Stock | 4.71 | -10.63% |
HURA TuHURA Biosciences, Inc. - Common Stock | 2.00 | -9.91% |